Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2
Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
The potential clinical utility of galanin peptidic analogs has been hindered by poor metabolic stability, lack of brain penetration, and hyperglycemia. In addition to possessing potent anticonvulsant efficacy, galanin analogs are analgesic in various assays. The purpose of these studies was to evaluate the lead galanin receptor type 2 (GalR2)-prefe...
Alternative Titles
Full title
Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5505798
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5505798
Other Identifiers
ISSN
0364-3190
E-ISSN
1573-6903
DOI
10.1007/s11064-017-2229-5
